Catch Up With Our Recent Issues Over the Holiday
Catch Up With Our Recent Issues Over the Holiday
In case you have some time downtime, here's a handy list of links to everything we've published recently.
In case you're taking time off for Thanksgiving and need some RA/QA news and analysis to go along with turkey and football, then we have the links for you.
Here’s a handy list of links to everything we’ve published over the past few weeks for anyone who needs to catch up.
1.
A wonderful discussion of the practical ways teams can establish a genuine Quality Culture through a focus on communication pathways.
2.
FDA’s OPQ recently announced it’s reorganizing itself in January. We penned a few of our thoughts on what it could mean for industry teams.
3.
A list of links to recent FDA and life science happenings throughout the first half of November.
4.
We speak with a veteran VP of Quality who shares his best practices for managing device suppliers.
5.
We gathered some of the tasks Quality teams often address in Q4 to ensure you’re on track to hit the ground running in the new year.
6.
We recently sat down with George Toscano, President & CEO of Toscano Consulting Group, to explore recent FDA enforcement trends and the nuances of the FDA inspection process, especially in light of the COVID-19 pandemic's impact on the industry.
7.
Managing a supplier audit program can be a challenge. Here are a few questions we see firms often miss during audit planning.
8.
We spoke with Jessica Smith Beaver, PhD, CEO of Verinetics, about career options in life science's quality and regulatory sector. We discussed the advantages and challenges of different paths and the importance of personal reflection in career development.
9.
In September, the FDA proposed a rule that would end the enforcement LDTs by treating them as IVDs. We broke down the news and what it means for potentially impacted labs and other firms.
10.
A list of links to recent FDA and life science happenings throughout the second half of October.
Want to go back further? Scroll through our entire issue archive.
A special thank you
From all of us at The FDA Group, we’d like to take a moment to express our gratitude for your subscription. We know your time, attention, and inbox space are valuable, and we hope this newsletter is well worth it.
If you have suggestions or comments, please don’t hesitate to share them with us by replying to this email. We read everything we receive.
Happy Thanksgiving to those who celebrate. 🦃
Who is The FDA Group?
The FDA Group helps life science organizations rapidly access the industry's best consultants, contractors, and candidates. Our resources assist in every stage of the product lifecycle, from clinical development to commercialization, with a focus on Quality Assurance, Regulatory Affairs, and Clinical Operations.
With over 2,500 resources worldwide, over 225 of whom are former FDA, we meet your precise resourcing needs through a fast, convenient talent selection process supported by a Total Quality Guarantee.